Mitsuhiro Takenoyama
National Hospital Organization Kyushu Cancer Center(JP)Matsuyama Red Cross Hospital(JP)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Immunotherapy and Immune Responses, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Clinical Efficacy and Safety of Nivolumab: Results of a M ulticenter, Op e n-label, Single-a r m, Japanese Phase II study in Mal i gnant Pleural Meso t helioma (MERIT)(2019)236 cited
- → Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status(2009)151 cited
- → A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors(2019)147 cited
- → Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non–Small-Cell Lung Cancer(2002)137 cited
- → A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study)(2016)122 cited